|
 |
|
You are here: Home
> Comments
What People Are Saying About Ventria:
“Diarrheal illnesses are a major reason for children
seeing their physician and a major cause of emergency room visits.
Oral rehydration is a safe, effective way to treat most diarrheal
illnesses. This study confirms the advantages of adding proteins
contained in breast milk to oral rehydration solution. It’s
important because decreasing the duration of diarrhea lessens the
likelihood of children becoming significantly dehydrated and it
allows children to return to daycare and school sooner.”
Robert Wittler, M.D., Professor, Pediatric Infectious Diseases,
Kansas University School of Medicine at Wichita, Op-ed dated March
19,
2007 discussing Ventria's Child Health Study
“Farmers stand to benefit, as those
who grow the rice can earn a premium compared to their next
most lucrative crop.
They
also have the satisfaction of knowing they are helping provide
affordable healthcare products to children who desperately need
it.”
Kansas Agriculture Secretary Adrian Polansky, Op-ed dated
March 19, 2007 discussing Ventria's production in Kansas
“The Ventria Bioscience project will
provide opportunities for Kansas growers to benefit from growing
this specialty crop
under a closely monitored and closed system. With proper security
in place, we believe this project will benefit Kansas, and will
allow Ventria to produce affordable, life-saving medicines.”
Jere White, Executive Director, Kansas Corn Growers Association,
Kansas Grain Sorghum Producers Association, Open Comment Period,
USDA March 2007
“Oral rehydration therapy including electrolyte solution
is recommended by the American Academy of Pediatrics for dehydration
due to diarrhea. The idea of improving oral electrolyte therapy
with the addition of proteins naturally found in breast milk is
a novel and important concept and is potentially a major advancement
in this therapy, which impacts the health of children globally”.
Ron Kleinman, M.D., Acting Chief of Pediatrics and Chief
of Pediatric Gastroenterology, MassGeneral Hospital for Children,
Press Release “Study
Finds that Electrolyte Solution with Lactiva and Lysomin Helps
Children
Recover Faster From Diarrhea” January 31, 2007
“The solution (literally and figuratively)
may be an ingenious, affordable innovation from Ventria Bioscience
that
combines high-
and low-tech. It is an improvement on current oral rehydration
that could be a veritable Holy Grail: two human proteins produced
inexpensively in rice that radically improve the effectiveness
of rehydration solutions.”
Henry I. Miller, M.D., a physician and fellow at the Hoover
Institution, Dr. Miller headed the FDA's Office of Biotechnology
from 1989 to 1993. Op-ed “The
Holy Grail in a Grain of Rice”, June 26, 2007
"Diarrhea is a dreadful disease that preys worldwide
upon the most innocent and the most vulnerable groups of people:
children,
the elderly and the poor. This innovative
science promises to provide new solutions to a long-standing
public health problem. We applaud this effort."
Hilmar Stolte, M.D., president of the International Academy
of Life Sciences (IALS), Press Release “International Academy
of Life Sciences Applauds Novel Product for Diarrhea” June
26, 2006
“I am hoping that (Lactiva and Lysomin) might be the first
thing that would be widely added to oral hydration, which is consumed
by at least half of the world’s children. This is
what we call the Holy Grail. We’d like to have something
that both hydrated people and could shorten the illness. That is
what every mother would want for their child.”
Dr. William Greenough III, Professor of Medicine at John
Hopkins University and a world-renowned expert in pediatric and
geriatric
diarrhea, “Lactiva and Lysomin: Helping to Save Lives By
Improving Oral Rehydration Solution - Making Innovative Diarrhea
Management Accessible” May 1, 2006
“Ventria Bioscience is engaged in work
that is overwhelmingly beneficial to society, particularly
poor children who suffer and
die from diarrhea. All people, wealthy Americans as well as the
poor of the world, need access to effective medicines. Access fails
when costs and demand prevent the adequate production of needed
medicines. Ventria has a product urgently needed for human health.
Ventria has a production system that enhances supply at greatly
reduced costs.”
Drew L. Kershen, Earl Sneed Centennial Professor of Law,
University of Oklahoma College of Law, Open Comment Period, USDA
March, 2005
If you have questions about Ventria, please contact us at:
Email: info@ventria.com
| Copyright 2002© Ventria
Bioscience. All Rights Reserved. |
|
 |